Disclaimer: The medications discussed in this article may include compounded preparations from a licensed 503A compounding pharmacy. Compounded medications have not been reviewed or approved by the FDA and are not the same as commercially available FDA-approved products. This content is for educational purposes only and does not constitute medical advice or establish a provider-patient relationship. Please consult a licensed healthcare provider for personalized clinical guidance.
Glutathione is a molecule your body makes constantly, which leads many people to assume supplementing it carries no risk. For oral forms at the doses studied, that assumption holds up reasonably well. For injectable and especially intravenous forms, the picture is less reassuring, and the difference comes down to dose, route, and how the product was made. This article covers what the trials report, what the case reports and regulatory warnings add, and who our providers screen out.
What the Oral Trials Report
The best safety data comes from the controlled trials of oral glutathione, because they ran the longest and tracked participants most carefully.
A 2015 randomized trial gave 54 adults 250 or 1,000 mg of oral glutathione daily for six months with blood work at one, three, and six months. The study reported increases in glutathione stores and no safety concerns at either dose.[1] A 2011 trial from Bastyr University gave 40 adults 500 mg twice daily for four weeks and likewise reported no adverse effects, though it also found no change in oxidative stress markers over that short window.[2] A 2018 pilot of liposomal glutathione at 500 and 1,000 mg daily for one month in 12 adults reported no adverse events.[3]
Across those studies, the side effects that do appear at oral doses are mild and gastrointestinal: bloating, loose stools, and abdominal cramping in some participants, more often at the higher doses.
Injectable and IV Glutathione
Subcutaneous injection of compounded glutathione carries the side effects of any injection: redness, mild swelling, or tenderness at the site. Allergic or hypersensitivity reactions are uncommon but possible with any injected medication, including compounded glutathione products.
Intravenous glutathione is where the most significant safety concerns have been reported, likely reflecting a combination of higher doses, repeated administration, product quality issues, and limited long-term safety data. IV protocols, particularly those marketed for skin lightening, often deliver far larger amounts than anything studied orally. A 2016 review of glutathione as a skin-lightening agent documented adverse effects from intravenous use serious enough that the Philippine Food and Drug Administration issued a public warning against it. The review found no evidence of efficacy for the IV route.[4] Reported adverse effects in that literature include abdominal pain, kidney dysfunction, thyroid effects, and severe skin reactions, most tied to high-dose, repeated IV administration in unregulated settings.
The FDA in the United States has also issued warnings about specific lots of glutathione for injection contaminated with high levels of endotoxin, which caused adverse reactions in patients. This is a sourcing problem rather than a glutathione problem, and it is the reason the pharmacy matters as much as the molecule.
Who Should Avoid Glutathione
Our providers do not prescribe glutathione for people who:
Have asthma. Inhaled glutathione has triggered bronchospasm in some asthmatic patients, and while that is a different route, caution carries over.
Are pregnant or breastfeeding. There is no safety data in either group.
Have a known allergy to glutathione or to any component of the compounded preparation.
Are seeking it for skin lightening, which is not an indication we support and is the context in which the serious adverse effects have occurred.
Have active cancer under treatment, unless their oncologist is involved. Glutathione’s antioxidant activity has a theoretical potential to interfere with some chemotherapy and radiation mechanisms, and that decision belongs with the treating oncologist.
Interactions
Few clinically significant drug interactions have been well documented, although interaction data remain limited. The one that matters is the theoretical interaction with cancer treatment above. Alcohol depletes glutathione, which is sometimes cited as a reason to supplement, but it is not a reason to combine the two with any expectation of protection.
What Monitoring Looks Like
For patients in our program, glutathione is dispensed by a licensed 503A pharmacy at doses within the ranges that have oral and injectable use data behind them. Providers review health history before prescribing, with specific attention to the exclusions above, and patients report any injection-site or systemic reactions at check-ins.
In the limited studies available, glutathione administered at commonly used doses has generally been well tolerated, with mostly mild gastrointestinal side effects reported. The side effect profile of high-dose IV glutathione from an unregulated source is not. Knowing which one you are being offered is most of the safety question.
References
Richie JP Jr, Nichenametla S, Neidig W, et al. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr. 2015;54(2):251-263. PubMed: 24791752
Allen J, Bradley RD. Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers. J Altern Complement Med. 2011;17(9):827-833. PubMed: 21875351
Sinha R, Sinha I, Calcagnotto A, et al. Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function. Eur J Clin Nutr. 2018;72(1):105-111. PubMed: 28853742
Sonthalia S, Daulatabad D, Sarkar R. Glutathione as a skin whitening agent: Facts, myths, evidence and controversies. Indian J Dermatol Venereol Leprol. 2016;82(3):262-272. PubMed: 27088927
This article is for educational purposes only and does not constitute medical advice or establish a provider-patient relationship. Please consult a licensed healthcare provider for personalized guidance.
Angela Kifer, NP, is a licensed provider at Precision Telemed. This article has been reviewed for clinical accuracy.
